Item 9 Labs Corp. (INLB)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: May 12, 2025
Item 9 Labs Company Description
Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States.
The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware.
It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona.
It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name.
Item 9 Labs Corp. is headquartered in Phoenix, Arizona.
Item 9 Labs Corp.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 101 |
Contact Details
Address: 2727 North 3rd Street Phoenix, Delaware 85004 United States | |
| Phone | 833 867 6337 |
| Website | item9labscorp.com |
Stock Details
| Ticker Symbol | INLB |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | US46564C2035 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey I. Rassas | Strategic Advisor and Director |
| Jayne Levy | Senior Vice President of Communications |
| Kyle Jennings | Vice President of Marketing |
| Mark Busch | Senior Vice President of Corporate Development |
| Cory Carter | Senior Vice President of Cultivation |